affiliation not provided to SSRN
alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib
small cell lung cancer, lurbinectedin, real-world, effectiveness
Pleural Mesothelioma, Immunotherapy, perioperative, pleurectomy, multimodality